That’s correct... omitted the “digit” in the

That’s correct... omitted the “digit” in the statement. To correct it completely... and I will be paraphrasing somewhat.

Nader Pourhassan said:

This stock has the ability to become a high triple digit or quadruple digit stock price.

My interpretation of that statement is $600-$900 /share or maybe even $1,000/share for our stock price. That’s what I take his statement as... it’s easy to see with revenues and potentials of just a few of the big ticket indications in the works currently... Cancer, Nash, and a few other immunodeficiency diseases. Nash alone could have revenue between $200-$400 billion.

He didn’t list a date that would happen and Nader self admits that dates aren’t his thing having only been right 2 times out of a hundred date predictions. Easily forgiven by some of us. Some of us can’t forgive his lack of making realistic dates as a reality often going over his predictions. My hope is the big indications that save the most lives and have the highest revenue come first. 3-5 years seems reasonable to me to wait to get that high triple digit stock price. Maybe more...